跳至主要内容
临床试验/ACTRN12605000764639
ACTRN12605000764639尚未招募未知

The pharmacokinetics of plasma-derived Factor XIII in children with congential Factor XIII Deficiency.

Department of Clinical Haematology, Royal Children's Hospital, Parkville, Victoria0 个研究点目标入组 4 人开始时间: 2005年11月25日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
4

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • Proven FXIII deficiencypatient registered in the Haemophilia program at the Royal Children's HospitalInformed consent obtainedpatients are receiving or have previously received Fibrogammin P as part of their treatment regime.

排除标准

  • Patients with haematocrit <35%patients with platelet count <100active bleeding at the time of testingpatient unable to cooperate with study procedures.

研究者

发起方
Department of Clinical Haematology, Royal Children's Hospital, Parkville, Victoria

相似试验